Biotechnology company Sanobiotec, registered last year and implementing an oncologic research project in cooperation with Lithuania's National Cancer Institute, is setting up its activity at Vilnius City Innovation Industrial Park and plans to invest up to 8 million euros and create 80 new jobs, the Verslo Zinios business daily writes.
© DELFI / Kiril Čachovskij

The company will set up in an area of 55 acres and plans to build a research and experimental development center and administrative premises.

The construction is set to start in November, and the company plans to start its activities in 2021.

BNS
It is prohibited to copy and republish the text of this publication without a written permission from UAB „BNS“.

Prime Minister expects LNG terminal charge to be cut in December

Lithuanian Prime Minister Saulius Skvernelis expects that the Energy Ministry 's row with Achemos...

UK-based tech firm establishing developer team in Vilnius

The rapidly growing UK -based tech firm Velocity Black is establishing a developer team in its...

Central bank has no info on Swedbank's links to Syria's chemical weapons

The central Bank of Lithuania says it has no information to confirm claims by Swedish media about...

Vilnius to buy 50 new buses for EUR 19 mln

Vilnius will buy 50 new low-floor buses for 19.39 million euros from Adampolis , the Lithuanian...

Viciunai establishes enterprise in Tbilisi hoping to double sales

Viciunu Grupe (Viciunai Group), a business group controlled by Visvaldas Matijosaitis, mayor of...